Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo

Human Gene Therapy

Volumn 11, Issue 4, 2000, Pages 547-554

  He, Yukai ^a,b   Pimenov, Alexei A ^a   Nayak, Jayakar V ^a   Plowey, Jeff ^a   Falo Jr , Louis D ^a   Huang, Leaf ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE TARGETING; HYDRODYNAMICS; IMMUNOTHERAPY; LYMPHOID TISSUE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN SIZE; SPLEEN;

ANIMALS; CELL DIVISION; DENDRITIC CELLS; DNA; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSFECTION;

ANIMALIA;

EID: 0034008431     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015734     Document Type: Article

References (20)

1. Anderson, W.F. (1998). Human gene therapy. Nature (London) 392(Suppl.), 25-30.
2. Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the control of immunity. Nature (London) 392, 245-252.
3. Brasel, K., McKenna, H.J., Morrissey, P.J., Charrier, K., Morris, A.E., Lee, C.C., Williams, D.E., and Lyman, S.D. (1996). Hematologic effects of flt3 ligand in vivo in mice. Blood 88, 2004-2012.
4. Chen, K., Braun, S., Lyman, S., Fan, Y., Traycoff, C.M., Wiebke, E.A., Gaddy, J., Sledge, G., Broxmeyer, H.E., and Cornetta, K. (1997). Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 57, 3511-3516.
5. Esche, C., Subbotin, V.M., Maliszewski, C., Lotze, M.L., and Shurin, M.R. (1998). Flt3 ligand administration inhibit tumor growth in murine melanoma and lymphoma. Cancer Res. 58, 380-383.
6. Gao, X., and Huang, L. (1991). A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285.
7. Juan, T.S., McNiece, I.K., Van, G., Lacey, D., Hartley, C., McElroy, P., Sun, Y., Argento, J., Hill, D., Yan, X.Q., and Fletcher, F.A. (1997). Chronic expression of murine flt3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis. Blood 90, 76-84.
8. Li, S., Wu, S.P., Whitmore, M., Loeffert, E.J., Wang, L., Watkins, S.C., Pitt, B.R., and Huang, L. (1999). Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276(5, Pt. 1), L796-L804.
9. Liu, F., Song, Y.K., and Liu, D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266.
10. Lyman, S.D., James, L., Johnson, L., Brasel, K., De Vries, P., Escobar, S.S., Downey, H., Splett, R.R., Beckmann, M.P., and McKenna, H.J. (1994). Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83, 2795-2801.
11. Lyman, S.D., and Jacobsen, S.E. (1998). C-kit ligand and flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities. Blood 91, 1101-1134.
12. Lynch, D.H., Andreasen, A., Maraskovsky, E., Whitmore, J., Miller, R.E., and Schuh, J.C.L. (1997). Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nature Med. 3, 625-631.
13. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E.R., Lyman, S.D., Shortman, K., and McKenna, H.J. (1996). Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962.
14. Shaw, S.G., Maung, A.A., Steptoe, R.J., Thomson, A.W., and Vujanovic, N.L. (1998). Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: Implications for anti-cancer and anti-viral therapy. J. Immunol. 161, 2817-2824.
15. Shurin, M.R., Pandharipande, P.P., Zorina, T.D., Haluszczak, C., Subbotin, V.M., Hunter, O., Brumfield, A., Storkus, W.J., Maraskovsky, E., and Lotze, M.T. (1997). FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179, 174-184.
16. Steinman, R.M. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296.
17. Verma, I.M., and Somia, N. (1997). Gene therapy - promises, problems and prospects. Nature (London) 389, 239-242. [News]
18. Vujanovic, N.L., Polimeno, L., Azzarone, A., Francavilla, A., Chambers, W.H., Starzl, T.E., Herberman, R.B., and Whiteside, T.L. (1995). Changes of liver-resident NK cells during liver regeneration in rats. J. Immunol. 154, 6324-6338.
19. Yew, N.S., Wang, K.X., Przybylska, M., Bagley, R.G., Stedman, M., Marshall, J., Scheule, R.K., and Cheng, S.H. (1999). Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum. Gene Ther. 10, 223-234.
20. Zhang, G., Budker, V., and Wolff, J.A. (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735-1737.